formosa pharmaceuticals, inc. is a biopharmaceutical company that specializes in ophthalmology and oncology, with a focus on developing new drugs for the treatment of post-operative inflammation and pain following ocular surgery. Formosa Pharmaceuticals uses Active Pharmaceutical Nanoparticle Technology (APNT) to improve the dissolution and bioavailability of APIs for topical, oral, and inhaler administration. Their target markets include the United States, Macao, and the Middle East and North Africa.
Headquarters
8F-6, No. 57, Fuxing N. Rd
Taipei City; Taipei City;
Contact Details: Purchase the Formosa Pharmaceuticals, Inc. (台新药股份有限公司) report to view the information.
Website: http://www.formosapharma.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service